Investor Optimism Abounds Tri Chemical Laboratories Inc. (TSE:4369) But Growth Is Lacking

With a median price-to-earnings (or "P/E") ratio of close to 14x in Japan, you could be forgiven for feeling indifferent about Tri Chemical Laboratories Inc.'s (TSE:4369) P/E ratio of 15.4x. While this might not raise any eyebrows, if the P/E ratio is not justified investors could be missing out on a potential opportunity or ignoring looming disappointment.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

Recent times have been advantageous for Tri Chemical Laboratories as its earnings have been rising faster than most other companies. It might be that many expect the strong earnings performance to wane, which has kept the P/E from rising. If not, then existing shareholders have reason to be feeling optimistic about the future direction of the share price.

Check out our latest analysis for Tri Chemical Laboratories

If you'd like to see what analysts are forecasting going forward, you should check out our free report on Tri Chemical Laboratories.

Does Growth Match The P/E?

There's an inherent assumption that a company should be matching the market for P/E ratios like Tri Chemical Laboratories' to be considered reasonable.

If we review the last year of earnings growth, the company posted a terrific increase of 50%. The latest three year period has also seen a 8.4% overall rise in EPS, aided extensively by its short-term performance. So we can start by confirming that the company has actually done a good job of growing earnings over that time.

Turning to the outlook, the next year should generate growth of 0.7% as estimated by the five analysts watching the company. That's shaping up to be materially lower than the 9.0% growth forecast for the broader market.

In light of this, it's curious that Tri Chemical Laboratories' P/E sits in line with the majority of other companies. It seems most investors are ignoring the fairly limited growth expectations and are willing to pay up for exposure to the stock. These shareholders may be setting themselves up for future disappointment if the P/E falls to levels more in line with the growth outlook.

What We Can Learn From Tri Chemical Laboratories' P/E?

Typically, we'd caution against reading too much into price-to-earnings ratios when settling on investment decisions, though it can reveal plenty about what other market participants think about the company.

We've established that Tri Chemical Laboratories currently trades on a higher than expected P/E since its forecast growth is lower than the wider market. When we see a weak earnings outlook with slower than market growth, we suspect the share price is at risk of declining, sending the moderate P/E lower. This places shareholders' investments at risk and potential investors in danger of paying an unnecessary premium.

You always need to take note of risks, for example - Tri Chemical Laboratories has 2 warning signs we think you should be aware of.

If you're unsure about the strength of Tri Chemical Laboratories' business, why not explore our interactive list of stocks with solid business fundamentals for some other companies you may have missed.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.